Inventor · disambiguated record
Richard Charvet
Also filed as: CHARVET RICHARD
20 granted patents·17 pending applications·34 citations·filing 2009–2024
91Inventor score
Top patents by PatentIndex Score
37 records- 0192US9493583B2Anionic polysaccharides functionalized by a hydrophobic acid derivativeCHARVET RICHARD·Filed 2010·Granted Nov 15, 2016·9 cites·44 claims
- 0287US8426382B2Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivativeSOULA REMI·Filed 2010·Granted Apr 23, 2013·5 cites·26 claims
- 0385US9795678B2Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compoundADOCIA·Filed 2015·Granted Oct 24, 2017·3 cites·27 claims
- 0480US10583175B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2017·Granted Mar 10, 2020·2 cites·33 claims
- 0580US9700599B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2013·Granted Jul 11, 2017·3 cites·14 claims
- 0679US10485851B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2017·Granted Nov 26, 2019·3 cites·16 claims
- 0778US11191812B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2018·Granted Dec 7, 2021·1 cites·17 claims
- 0876US10548952B2Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2017·Granted Feb 4, 2020·2 cites·36 claims
- 0976US10383920B2Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2017·Granted Aug 20, 2019·2 cites·18 claims
- 1075US11633460B2Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Granted Apr 25, 2023·2 cites·15 claims
- 1175US2025090638A1Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acidADOCIA·Filed 2024·Application pending·0 cites
- 1273US9018190B2Functionalized oligosaccharidesCHARVET RICHARD·Filed 2012·Granted Apr 28, 2015·1 cites·4 claims
- 1370US10792335B2Rapid-acting insulin composition comprising a substituted citrateADOCIA·Filed 2016·Granted Oct 6, 2020·1 cites·21 claims
- 1464US12186373B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acidADOCIA·Filed 2021·Granted Jan 7, 2025·0 cites·12 claims
- 1562US2015314003A2Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymerADOCIA·Filed 2014·Application pending·0 cites
- 1662US2022409523A1Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acidADOCIA·Filed 2021·Application pending·0 cites
- 1761US10449256B2Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymerADOCIA·Filed 2018·Granted Oct 22, 2019·0 cites·10 claims
- 1861US2014235536A1Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is comprised in 5.8 and 8.5 and an anionic compound bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2014·Application pending·0 cites
- 1960US2021386830A1Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2021·Application pending·0 cites
- 2059US11883496B2Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2020·Granted Jan 30, 2024·0 cites·24 claims
- 2158US2018236085A1Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is comprised in 5.8 and 8.5 and an anionic compound bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Application pending·0 cites
- 2258US2017143835A1Substituted anionic compounds consisting of a backbone made up of a discrete number of saccharide unitsADOCIA·Filed 2017·Application pending·0 cites
- 2357US2013245246A1Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivativeADOCIA·Filed 2013·Application pending·0 cites
- 2456US11173109B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acidADOCIA·Filed 2018·Granted Nov 16, 2021·0 cites·18 claims
- 2553US2010167991A1Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivativeADOCIA·Filed 2009·Application pending·0 cites
- 2652US2019388515A1Injectable solution at ph 7 comprising at least one basal insulin the pi of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2019·Application pending·0 cites
- 2750US2014187499A1Substituted anionic compounds consisting of a backbone made up of a discrete number of saccharide unitsADOCIA·Filed 2013·Application pending·0 cites
- 2849US11576952B2Injectable solution at pH 7 comprising at least one basal insulin for which the pI is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Granted Feb 14, 2023·0 cites·18 claims
- 2949US11129877B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acidADOCIA·Filed 2018·Granted Sep 28, 2021·0 cites·13 claims
- 3049US10987426B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2018·Granted Apr 27, 2021·0 cites·23 claims
- 3146US2012295833A1Polysaccharides having an adjustable degree of functionalizationCHARVET RICHARD·Filed 2012·Application pending·0 cites
- 3245US2011112039A1Polysaccharides comprising carboxyl functional groups substituted via esterification by a hydrophobic alcoholADOCIA·Filed 2010·Application pending·0 cites
- 3344US2022040099A1Injectable solution at ph 7 comprising at least a basal insulin which pi is comprised between 5.8 and 8.5 and a copolyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Application pending·0 cites
- 3444US2011178011A1Polysaccharide/BMP complexes which are soluble at physiological pHADOCIA·Filed 2010·Application pending·0 cites
- 3543US9115218B2Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacerCHARVET RICHARD·Filed 2011·Granted Aug 25, 2015·0 cites·22 claims
- 3643US2012041079A1Dextran functionalized by hydrophobic amino acidsSOULA GERARD·Filed 2011·Application pending·0 cites
- 3741US2016015814A1Fast-acting insulin formulation comprising a substituted anionic compound and a polyanionic compoundADOCIA·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →